FDx Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,632
Closed -$345K 758
2022
Q2
$345K Buy
+3,632
New +$345K 0.01% 580
2022
Q1
Sell
-2,093
Closed -$271K 864
2021
Q4
$271K Sell
2,093
-6,783
-76% -$878K 0.01% 737
2021
Q3
$1.01M Sell
8,876
-2,162
-20% -$245K 0.03% 333
2021
Q2
$1.14M Buy
11,038
+2,536
+30% +$263K 0.04% 307
2021
Q1
$711K Buy
+8,502
New +$711K 0.03% 379
2020
Q1
Sell
-15,798
Closed -$1.23M 553
2019
Q4
$1.23M Sell
15,798
-1,020
-6% -$79.4K 0.07% 202
2019
Q3
$1.23M Buy
16,818
+2,424
+17% +$178K 0.09% 191
2019
Q2
$886K Sell
14,394
-432
-3% -$26.6K 0.03% 356
2019
Q1
$946K Sell
14,826
-12,366
-45% -$789K 0.04% 307
2018
Q4
$1.39M Buy
27,192
+309
+1% +$15.8K 0.11% 138
2018
Q3
$1.56M Buy
26,883
+2,316
+9% +$134K 0.06% 254
2018
Q2
$1.19M Sell
24,567
-19,203
-44% -$932K 0.04% 333
2018
Q1
$2.04M Sell
43,770
-7,446
-15% -$346K 0.06% 283
2017
Q4
$1.92M Sell
51,216
-2,277
-4% -$85.5K 0.05% 332
2017
Q3
$1.95M Buy
53,493
+11,706
+28% +$427K 0.05% 320
2017
Q2
$1.65M Sell
41,787
-1,470
-3% -$57.9K 0.05% 364
2017
Q1
$1.36M Buy
43,257
+28,899
+201% +$906K 0.04% 419
2016
Q4
$448K Buy
14,358
+3,150
+28% +$98.3K 0.01% 815
2016
Q3
$450K Buy
11,208
+1,317
+13% +$52.9K 0.02% 664
2016
Q2
$329K Sell
9,891
-4,044
-29% -$135K 0.01% 724
2016
Q1
$410K Sell
13,935
-1,395
-9% -$41K 0.02% 639
2015
Q4
$404K Buy
15,330
+4,746
+45% +$125K 0.02% 627
2015
Q3
$251K Buy
10,584
+372
+4% +$8.82K 0.02% 672
2015
Q2
$242K Buy
+10,212
New +$242K 0.01% 832
2015
Q1
Sell
-11,088
Closed -$235K 1887
2014
Q4
$235K Buy
+11,088
New +$235K 0.01% 806